Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$5.40
+2.7%
$5.25
$4.22
$8.90
$61.83M0.248,205 shs12,622 shs
Inogen, Inc. stock logo
INGN
Inogen
$6.90
+3.0%
$7.59
$4.13
$14.10
$162.50M1.06563,503 shs184,495 shs
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
$0.28
+3.7%
$0.34
$0.20
$2.46
$49.79M1.19636,580 shs196,050 shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$32.60
-0.9%
$36.16
$26.06
$48.41
$281.01M1.5713,365 shs11,772 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
+1.15%+1.64%+3.14%-2.41%-28.04%
Inogen, Inc. stock logo
INGN
Inogen
-0.74%-6.42%-5.23%+22.04%-50.00%
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
-5.76%-11.42%-20.60%-38.71%-88.40%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-2.63%+2.02%-12.06%-6.29%-28.46%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
0.9796 of 5 stars
3.53.00.00.00.00.00.6
Inogen, Inc. stock logo
INGN
Inogen
2.8137 of 5 stars
1.04.00.03.92.21.71.3
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
1.5185 of 5 stars
3.02.00.00.01.82.50.6
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.5057 of 5 stars
3.52.00.00.02.31.70.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
3.00
Buy$11.00103.70% Upside
Inogen, Inc. stock logo
INGN
Inogen
2.00
Hold$7.508.70% Upside
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
2.00
Hold$0.67135.32% Upside
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$44.0034.97% Upside

Current Analyst Ratings

Latest SMTI, RBOT, INGN, and CLGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
Inogen, Inc. stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/5/2024
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
3/27/2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$49.00 ➝ $44.00
3/5/2024
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$1.50 ➝ $1.00
2/15/2024
Inogen, Inc. stock logo
INGN
Inogen
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
2/6/2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$49.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$10.96M5.64N/AN/A$2.47 per share2.19
Inogen, Inc. stock logo
INGN
Inogen
$315.66M0.51N/AN/A$8.79 per share0.78
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/A$0.56 per shareN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$64.99M4.32N/AN/A$5.22 per share6.25

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-$7.02M-$0.64N/AN/AN/A-64.05%-22.17%-18.84%5/22/2024 (Estimated)
Inogen, Inc. stock logo
INGN
Inogen
-$102.45M-$4.41N/AN/AN/A-32.46%-38.98%-27.03%5/7/2024 (Confirmed)
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
-$71.07M-$0.49N/AN/AN/AN/A-82.61%-63.88%4/29/2024 (Confirmed)
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$4.30M-$0.52N/AN/A-6.62%-11.12%-7.11%5/20/2024 (Estimated)

Latest SMTI, RBOT, INGN, and CLGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Inogen, Inc. stock logo
INGN
Inogen
-$0.76N/A+$0.76N/AN/AN/A  
4/29/2024N/A
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
-$0.10N/A+$0.10N/AN/AN/A  
3/25/2024Q4 2023
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/A-$0.03-$0.03-$0.03N/A$17.69 million
3/4/202412/31/2023
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
-$0.12-$0.07+$0.05-$0.08N/AN/A    
2/27/2024Q4 2023
Inogen, Inc. stock logo
INGN
Inogen
-$0.65-$1.14-$0.49-$1.14$78.09 million$75.90 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/AN/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A
8.62
8.40
Inogen, Inc. stock logo
INGN
Inogen
N/A
2.86
2.55
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
N/A
13.87
13.87
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
0.20
1.38
1.04

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
21.69%
Inogen, Inc. stock logo
INGN
Inogen
89.94%
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
47.27%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%

Insider Ownership

CompanyInsider Ownership
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
9.60%
Inogen, Inc. stock logo
INGN
Inogen
0.64%
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
14.73%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
55.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
7311.45 million10.35 millionOptionable
Inogen, Inc. stock logo
INGN
Inogen
83423.55 million23.40 millionOptionable
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
3175.75 million149.86 millionOptionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1078.62 million3.86 millionNot Optionable

SMTI, RBOT, INGN, and CLGN Headlines

SourceHeadline
Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) & Sanara MedTech (NASDAQ:SMTI) Head-To-Head ReviewShandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) & Sanara MedTech (NASDAQ:SMTI) Head-To-Head Review
americanbankingnews.com - April 21 at 1:44 AM
Sanara MedTech Inc. Announces $55 Million Debt FacilitySanara MedTech Inc. Announces $55 Million Debt Facility
globenewswire.com - April 18 at 9:15 AM
Sanara MedTech (NASDAQ:SMTI)  Shares Down 0.2% Sanara MedTech (NASDAQ:SMTI) Shares Down 0.2%
marketbeat.com - April 18 at 12:40 AM
Sanara Medtech Inc (SMTI)Sanara Medtech Inc (SMTI)
investing.com - April 11 at 7:36 AM
Sanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-marketSanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-market
markets.businessinsider.com - April 5 at 10:14 AM
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy OfficerSanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
globenewswire.com - April 5 at 9:00 AM
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call TranscriptSanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 29 at 9:57 AM
Sanara MedTech Inc. (SMTI) Q4 2023 Earnings Call TranscriptSanara MedTech Inc. (SMTI) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 28 at 1:54 PM
Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00
marketbeat.com - March 27 at 10:15 AM
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 25 at 9:39 PM
Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023
finance.yahoo.com - March 25 at 7:09 PM
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 ResultsSanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
globenewswire.com - March 25 at 4:05 PM
Sanara MedTechs Earnings: A PreviewSanara MedTech's Earnings: A Preview
benzinga.com - March 22 at 4:38 PM
Investors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five yearsInvestors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five years
finance.yahoo.com - March 13 at 12:55 PM
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call DatesSanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
globenewswire.com - March 13 at 9:15 AM
Cyient partners with MassMedic to accelerate MedTech innovationCyient partners with MassMedic to accelerate MedTech innovation
pharmabiz.com - March 6 at 6:08 PM
CGI Cellerate RX, LLCs Net WorthCGI Cellerate RX, LLC's Net Worth
benzinga.com - March 6 at 6:08 PM
Sanara MedTech Stock (NASDAQ:SMTI), Analyst Ratings, Price Targets, PredictionsSanara MedTech Stock (NASDAQ:SMTI), Analyst Ratings, Price Targets, Predictions
benzinga.com - February 23 at 2:58 AM
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
globenewswire.com - February 22 at 9:15 AM
Sanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To ProfitSanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To Profit
finance.yahoo.com - January 5 at 8:20 AM
Sanara MedTech announces exclusive license agreement for patented collagen peptidesSanara MedTech announces exclusive license agreement for patented collagen peptides
msn.com - January 3 at 1:43 PM
Sanara MedTech Inks Exclusive License Agreement With Tufts UniversitySanara MedTech Inks Exclusive License Agreement With Tufts University
markets.businessinsider.com - January 3 at 1:43 PM
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen PeptidesSanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
finance.yahoo.com - January 3 at 1:43 PM
Sanara MedTech Inc.s (NASDAQ:SMTI) top owners are retail investors with 32% stake, while 31% is held by insidersSanara MedTech Inc.'s (NASDAQ:SMTI) top owners are retail investors with 32% stake, while 31% is held by insiders
finance.yahoo.com - December 4 at 1:18 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CollPlant Biotechnologies logo

CollPlant Biotechnologies

NASDAQ:CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Inogen logo

Inogen

NASDAQ:INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Vicarious Surgical logo

Vicarious Surgical

NYSE:RBOT
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Sanara MedTech logo

Sanara MedTech

NASDAQ:SMTI
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.